Episode 40 - Accu-Chek SmartGuide: CGM Generation 2.0 for MDI | Amy Jolley | GNL Podcast

Suggest guests or get in contactPeople on MDI have had one generation of CGM technology: a sensor that tells you what your glucose is doing now, with a 15-minute trend arrow. While pump users have moved through five iterations, injection users have been waiting. The Accu-Chek SmartGuide is the first attempt at a second generation - and this episode asks whether it delivers.Amy Jolley is a Highly Specialised Dietitian, Lead Educator at the Diabetes Technology Network UK, and Lead for the Young Adult and Transition Service at Salford NHS Foundation Trust. This episode is not endorsed by Roche Diagnostics, but the experience of a healthcare professional's experience of putting 17 people onto the SmartGuide in one week, running group onboarding sessions, and asking them to come back and tell her what actually happened. Her host, John Pemberton, is founder of The Glucose Never Lies® and a person living with T1D. This episode covers:- Why MDI has been stuck at Generation 1 while pump technology moved through five iterations- Night Low Predict: RAG ratings, first-half versus second-half of the night, and how to teach it- Glucose Predict: the 45-minute action window versus the two-hour awareness window- What 17 early adopters actually reported back- How the 45-minute look ahead reduces the rage bolus- Why calibration is an educational opportunity, not a drawback- CGM market saturation and the DTN quality standard- The DTN Competency Assessment Framework: four tiers, self-assessment, a training passport for clinicians- GNL Grace in clinical practice: Amy's feedback from a specialist service supporting 700 AID usersShow notes: https://theglucoseneverlies.com/accu-chek-smartguide-mdi-cgm-series/Have more questions? Ask GNL Grace, a diabetes educational advisor built by a team with skin in the game. Grace gets you 80% of the way there with 20% of the effort; the final 20% takes self-discovery, guided by human expertise and trial-and-error learning. https://theglucoseneverlies.com/gnl-grace/---DisclaimerThis podcast is for education and informational purposes only. It does not constitute medical advice and is not a substitute for individualised care.The Glucose Never Lies® is independent by designWe do not accept sponsorships and advertising. We operate via education grants and donations from listeners who value independence. So, consider:Buying the GNL a Coffee: https://www.buymeacoffee.com/gnlfreeEnquiriesCollaboration: John Pemberton, [email protected]: Anjanee Kohli, [email protected] The Glucose Never Lies®Website: https://theglucoseneverlies.com/Instagram: https://www.instagram.com/theglucoseneverliesLinkedIn: https://www.linkedin.com/company/theglucoseneverliesLinkedIn John Pemberton: https://www.linkedin.com/in/john-pemberton-587104361/LinkedIn Anjanee Kohli: https://www.linkedin.com/in/anjanee-kohli-chohan-1b22a217b/Instagram Anjanee Kohli: https://www.instagram.com/anjanee.dietitianX: https://twitter.com/GlucoseNLiesDisclaimerThis podcast is for education and informational purposes only. It does not constitute medical advice and is not a substitute for individualised care.The Glucose Never Lies® is independent by designWe do not accept sponsorships and advertising. We operate via education grants and donations from listeners who value independence. So, consider:Buying the GNL a Coffee:https://www.buymeacoffee.com/jspfree2EnquiriesCollaboration: John Pemberton — [email protected]: Anjanee Kohli — [email protected] The Glucose Never Lies®Website: https://theglucoseneverlies.com/Instagram: https://www.instagram.com/theglucoseneverliesLinkedIn: https://www.linkedin.com/company/theglucoseneverliesLinkedIn: John Pemberton: https://www.linkedin.com/in/john-pemberton-587104361/X: https://twitter.com/GlucoseNLiesDisclaimer This content is for informational purposes only and does not constitute medical advice.© The Glucose Never Lies Ltd. All rights reserved.